Full text
PDFPage 713
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Henkind P., Ashton N. Ocular pathology in homocystinuria. Trans Ophthalmol Soc U K. 1965;85:21–38. [PubMed] [Google Scholar]
- Hoogeveen E. K., Kostense P. J., Beks P. J., Mackaay A. J., Jakobs C., Bouter L. M., Heine R. J., Stehouwer C. D. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study. Arterioscler Thromb Vasc Biol. 1998 Jan;18(1):133–138. doi: 10.1161/01.atv.18.1.133. [DOI] [PubMed] [Google Scholar]
- Mudd S. H., Havlik R., Levy H. L., McKusick V. A., Feinleib M. A study of cardiovascular risk in heterozygotes for homocystinuria. Am J Hum Genet. 1981 Nov;33(6):883–893. [PMC free article] [PubMed] [Google Scholar]
- Ou T., Yamakawa-Kobayashi K., Arinami T., Amemiya H., Fujiwara H., Kawata K., Saito M., Kikuchi S., Noguchi Y., Sugishita Y. Methylenetetrahydrofolate reductase and apolipoprotein E polymorphisms are independent risk factors for coronary heart disease in Japanese: a case-control study. Atherosclerosis. 1998 Mar;137(1):23–28. doi: 10.1016/s0021-9150(97)00244-x. [DOI] [PubMed] [Google Scholar]
- Still R. A., McDowell I. F. ACP Broadsheet No 152: March 1998. Clinical implications of plasma homocysteine measurement in cardiovascular disease. J Clin Pathol. 1998 Mar;51(3):183–188. doi: 10.1136/jcp.51.3.183. [DOI] [PMC free article] [PubMed] [Google Scholar]
- den Heijer M., Brouwer I. A., Bos G. M., Blom H. J., van der Put N. M., Spaans A. P., Rosendaal F. R., Thomas C. M., Haak H. L., Wijermans P. W. Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers. Arterioscler Thromb Vasc Biol. 1998 Mar;18(3):356–361. doi: 10.1161/01.atv.18.3.356. [DOI] [PubMed] [Google Scholar]